Cargando…

Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning

BACKGROUND: The human ATP binding cassette transporters Breast Cancer Resistance Protein (BCRP) and Multidrug Resistance Protein 1 (P-gp) are co-expressed in many tissues and barriers, especially at the blood–brain barrier and at the hepatocyte canalicular membrane. Understanding their interplay in...

Descripción completa

Detalles Bibliográficos
Autores principales: Montanari, Floriane, Zdrazil, Barbara, Digles, Daniela, Ecker, Gerhard F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743411/
https://www.ncbi.nlm.nih.gov/pubmed/26855674
http://dx.doi.org/10.1186/s13321-016-0121-y
_version_ 1782414362825195520
author Montanari, Floriane
Zdrazil, Barbara
Digles, Daniela
Ecker, Gerhard F.
author_facet Montanari, Floriane
Zdrazil, Barbara
Digles, Daniela
Ecker, Gerhard F.
author_sort Montanari, Floriane
collection PubMed
description BACKGROUND: The human ATP binding cassette transporters Breast Cancer Resistance Protein (BCRP) and Multidrug Resistance Protein 1 (P-gp) are co-expressed in many tissues and barriers, especially at the blood–brain barrier and at the hepatocyte canalicular membrane. Understanding their interplay in affecting the pharmacokinetics of drugs is of prime interest. In silico tools to predict inhibition and substrate profiles towards BCRP and P-gp might serve as early filters in the drug discovery and development process. However, to build such models, pharmacological data must be collected for both targets, which is a tedious task, often involving manual and poorly reproducible steps. RESULTS: Compounds with inhibitory activity measured against BCRP and/or P-gp were retrieved by combining Open Data and manually curated data from literature using a KNIME workflow. After determination of compound overlap, machine learning approaches were used to establish multi-label classification models for BCRP/P-gp. Different ways of addressing multi-label problems are explored and compared: label-powerset, binary relevance and classifiers chain. Label-powerset revealed important molecular features for selective or polyspecific inhibitory activity. In our dataset, only two descriptors (the numbers of hydrophobic and aromatic atoms) were sufficient to separate selective BCRP inhibitors from selective P-gp inhibitors. Also, dual inhibitors share properties with both groups of selective inhibitors. Binary relevance and classifiers chain allow improving the predictivity of the models. CONCLUSIONS: The KNIME workflow proved a useful tool to merge data from diverse sources. It could be used for building multi-label datasets of any set of pharmacological targets for which there is data available either in the open domain or in-house. By applying various multi-label learning algorithms, important molecular features driving transporter selectivity could be retrieved. Finally, using the dataset with missing annotations, predictive models can be derived in cases where no accurate dense dataset is available (not enough data overlap or no well balanced class distribution). [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13321-016-0121-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4743411
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-47434112016-02-06 Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning Montanari, Floriane Zdrazil, Barbara Digles, Daniela Ecker, Gerhard F. J Cheminform Research Article BACKGROUND: The human ATP binding cassette transporters Breast Cancer Resistance Protein (BCRP) and Multidrug Resistance Protein 1 (P-gp) are co-expressed in many tissues and barriers, especially at the blood–brain barrier and at the hepatocyte canalicular membrane. Understanding their interplay in affecting the pharmacokinetics of drugs is of prime interest. In silico tools to predict inhibition and substrate profiles towards BCRP and P-gp might serve as early filters in the drug discovery and development process. However, to build such models, pharmacological data must be collected for both targets, which is a tedious task, often involving manual and poorly reproducible steps. RESULTS: Compounds with inhibitory activity measured against BCRP and/or P-gp were retrieved by combining Open Data and manually curated data from literature using a KNIME workflow. After determination of compound overlap, machine learning approaches were used to establish multi-label classification models for BCRP/P-gp. Different ways of addressing multi-label problems are explored and compared: label-powerset, binary relevance and classifiers chain. Label-powerset revealed important molecular features for selective or polyspecific inhibitory activity. In our dataset, only two descriptors (the numbers of hydrophobic and aromatic atoms) were sufficient to separate selective BCRP inhibitors from selective P-gp inhibitors. Also, dual inhibitors share properties with both groups of selective inhibitors. Binary relevance and classifiers chain allow improving the predictivity of the models. CONCLUSIONS: The KNIME workflow proved a useful tool to merge data from diverse sources. It could be used for building multi-label datasets of any set of pharmacological targets for which there is data available either in the open domain or in-house. By applying various multi-label learning algorithms, important molecular features driving transporter selectivity could be retrieved. Finally, using the dataset with missing annotations, predictive models can be derived in cases where no accurate dense dataset is available (not enough data overlap or no well balanced class distribution). [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13321-016-0121-y) contains supplementary material, which is available to authorized users. Springer International Publishing 2016-02-04 /pmc/articles/PMC4743411/ /pubmed/26855674 http://dx.doi.org/10.1186/s13321-016-0121-y Text en © Montanari et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Montanari, Floriane
Zdrazil, Barbara
Digles, Daniela
Ecker, Gerhard F.
Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning
title Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning
title_full Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning
title_fullStr Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning
title_full_unstemmed Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning
title_short Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning
title_sort selectivity profiling of bcrp versus p-gp inhibition: from automated collection of polypharmacology data to multi-label learning
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743411/
https://www.ncbi.nlm.nih.gov/pubmed/26855674
http://dx.doi.org/10.1186/s13321-016-0121-y
work_keys_str_mv AT montanarifloriane selectivityprofilingofbcrpversuspgpinhibitionfromautomatedcollectionofpolypharmacologydatatomultilabellearning
AT zdrazilbarbara selectivityprofilingofbcrpversuspgpinhibitionfromautomatedcollectionofpolypharmacologydatatomultilabellearning
AT diglesdaniela selectivityprofilingofbcrpversuspgpinhibitionfromautomatedcollectionofpolypharmacologydatatomultilabellearning
AT eckergerhardf selectivityprofilingofbcrpversuspgpinhibitionfromautomatedcollectionofpolypharmacologydatatomultilabellearning